Propofol inhibits activation of the mammalian target of rapamycin (mTOR)/p70S6K pathway (Zhang et al., 2015) and modulates the HOTAIR/miR-129-5p/ribosomal protein L14 (RPL14) axis (Sun et al., 2021) by decreasing HOTAIR expression, which subsequently inhibits the growth of cervical cancer cells. This evidence concerns the gene RPL14 and cervical cancer.